Search

Kendra D. Carter

Examiner (ID: 7816)

Most Active Art Unit
1627
Art Unit(s)
1648, 1627, 1617, 3785
Total Applications
954
Issued Applications
357
Pending Applications
39
Abandoned Applications
556

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10241506 [patent_doc_number] => 20150126501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'Fused Ring Compound For Use As Mineralocorticoid Receptor Antagonist' [patent_app_type] => utility [patent_app_number] => 14/591081 [patent_app_country] => US [patent_app_date] => 2015-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20376 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14591081 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/591081
Fused ring compound for use as mineralocorticoid receptor antagonist Jan 6, 2015 Issued
Array ( [id] => 10367015 [patent_doc_number] => 20150252020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'Intramolecular Hydrogen-Bonded Nitric Oxide Synthase Inhibitors' [patent_app_type] => utility [patent_app_number] => 14/589690 [patent_app_country] => US [patent_app_date] => 2015-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7128 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589690 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/589690
Intramolecular hydrogen-bonded nitric oxide synthase inhibitors Jan 4, 2015 Issued
Array ( [id] => 10367015 [patent_doc_number] => 20150252020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'Intramolecular Hydrogen-Bonded Nitric Oxide Synthase Inhibitors' [patent_app_type] => utility [patent_app_number] => 14/589690 [patent_app_country] => US [patent_app_date] => 2015-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7128 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589690 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/589690
Intramolecular hydrogen-bonded nitric oxide synthase inhibitors Jan 4, 2015 Issued
Array ( [id] => 11270454 [patent_doc_number] => 20160333002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => 'N, N\' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/105702 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 31593 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105702 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/105702
N,N' substituted piperidinamine compounds, and preparation method and usage thereof Dec 18, 2014 Issued
Array ( [id] => 11121954 [patent_doc_number] => 20160318929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 15/108400 [patent_app_country] => US [patent_app_date] => 2014-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48291 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108400 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/108400
Pyrazolo[1,5-a]pyridine derivatives and methods of their use Dec 17, 2014 Issued
Array ( [id] => 13034345 [patent_doc_number] => 10039282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-07 [patent_title] => Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides [patent_app_type] => utility [patent_app_number] => 15/104004 [patent_app_country] => US [patent_app_date] => 2014-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31745 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 256 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104004 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/104004
Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides Dec 11, 2014 Issued
Array ( [id] => 11729283 [patent_doc_number] => 20170190726 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-07-06 [patent_title] => 'PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/102700 [patent_app_country] => US [patent_app_date] => 2014-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102700 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/102700
PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR Dec 11, 2014 Abandoned
Array ( [id] => 11729283 [patent_doc_number] => 20170190726 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-07-06 [patent_title] => 'PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/102700 [patent_app_country] => US [patent_app_date] => 2014-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102700 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/102700
PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR Dec 11, 2014 Abandoned
Array ( [id] => 11289111 [patent_doc_number] => 20160339043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR REDUCING INTRAOCULAR PRESSURE' [patent_app_type] => utility [patent_app_number] => 15/102201 [patent_app_country] => US [patent_app_date] => 2014-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11329 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102201 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/102201
Compositions and methods for reducing intraocular pressure Dec 3, 2014 Issued
Array ( [id] => 11698770 [patent_doc_number] => 09688674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Selective EP4 receptor antagonistic substance for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 14/547247 [patent_app_country] => US [patent_app_date] => 2014-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 19628 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14547247 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/547247
Selective EP4 receptor antagonistic substance for treatment of cancer Nov 18, 2014 Issued
Array ( [id] => 11612533 [patent_doc_number] => 09650383 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-16 [patent_title] => 'Aldose reductase inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/541365 [patent_app_country] => US [patent_app_date] => 2014-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14940 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14541365 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/541365
Aldose reductase inhibitors and uses thereof Nov 13, 2014 Issued
Array ( [id] => 11075631 [patent_doc_number] => 20160272596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'TETRAHYDRO-BENZODIAZEPINONES' [patent_app_type] => utility [patent_app_number] => 15/037240 [patent_app_country] => US [patent_app_date] => 2014-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78707 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037240 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/037240
Tetrahydro-benzodiazepinones Nov 13, 2014 Issued
Array ( [id] => 11067594 [patent_doc_number] => 20160264558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => 'FLUOROGENIC PROTECTING GROUP' [patent_app_type] => utility [patent_app_number] => 15/036302 [patent_app_country] => US [patent_app_date] => 2014-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9434 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036302 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/036302
FLUOROGENIC PROTECTING GROUP Nov 12, 2014 Abandoned
Array ( [id] => 11075632 [patent_doc_number] => 20160272595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'QUINAZOLINONE AND ISOQUINOLINONE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 15/030804 [patent_app_country] => US [patent_app_date] => 2014-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 73821 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030804 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/030804
Quinazolinone and isoquinolinone derivative Oct 22, 2014 Issued
Array ( [id] => 9839693 [patent_doc_number] => 20150031775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'COMPOSITION AND METHOD FOR AFFECTING MALE AND FEMALE HORMONE LEVELS' [patent_app_type] => utility [patent_app_number] => 14/511844 [patent_app_country] => US [patent_app_date] => 2014-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10324 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511844 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/511844
COMPOSITION AND METHOD FOR AFFECTING MALE AND FEMALE HORMONE LEVELS Oct 9, 2014 Abandoned
Array ( [id] => 9806609 [patent_doc_number] => 20150018551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'CYCLOALKANE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/502708 [patent_app_country] => US [patent_app_date] => 2014-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 125422 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502708 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/502708
Cycloalkane derivatives Sep 29, 2014 Issued
Array ( [id] => 9806481 [patent_doc_number] => 20150018426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety' [patent_app_type] => utility [patent_app_number] => 14/502552 [patent_app_country] => US [patent_app_date] => 2014-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11788 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502552 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/502552
Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety Sep 29, 2014 Abandoned
Array ( [id] => 11243610 [patent_doc_number] => 09469643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-18 [patent_title] => 'Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one' [patent_app_type] => utility [patent_app_number] => 14/493261 [patent_app_country] => US [patent_app_date] => 2014-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 20136 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493261 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/493261
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one Sep 21, 2014 Issued
Array ( [id] => 11009650 [patent_doc_number] => 20160206603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'COMPOSITION COMPRISING TORASEMIDE AND BACLOFEN FOR TREATING NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/914666 [patent_app_country] => US [patent_app_date] => 2014-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22952 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914666 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/914666
Composition comprising torasemide and baclofen for treating neurological disorders Aug 31, 2014 Issued
Array ( [id] => 11010931 [patent_doc_number] => 20160207883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'NOVEL AROMATIC COMPOUND AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/914941 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53655 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914941 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/914941
Aromatic compound and use thereof Aug 28, 2014 Issued
Menu